about
Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors.Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.Overcoming antifungal resistance.Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility.Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse.Species distribution and susceptibility to azole antifungals of Candida bloodstream isolates from eight university hospitals in Korea.In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies.Pharmacokinetics and pharmacodynamics of antifungals in children and their clinical implications.Synthesis and chain-dependent antifungal activity of long-chain 2H-azirine-carboxylate esters related to dysidazirine.Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.In vitro activity of natural phenolic compounds against fluconazole-resistant Candida species: a quantitative structure-activity relationship analysis.[Reevaluation of Candida susceptibility to amphotericin B: comparative study using isolates from three hospitals in the state of Rio Grande do Sul].Clinical and experimental evaluation of a new chromogenic medium (OCCA, Oxoid) for direct identification of Candida albicans, C. tropicalis and C. krusei.
P2860
Q31936121-1A48FA47-CE8F-42EF-8B7A-8A48854BC3A4Q33183542-FAA91182-8F7C-4895-B243-9AEDA2AA76D7Q33651853-7DEB1714-0AB6-4774-B62D-0EBBD7AFC2E3Q33798458-43A7BF79-043A-4D11-9D79-58278539DBA1Q34202154-AB390AD0-7639-4433-926B-DE046D0B37DCQ34768569-EF7EDDE2-E3B9-4268-9D11-B819A9779229Q35714132-F93EDE9B-53FC-4FCC-833A-922E6DF79AD6Q35917505-B2A12B5D-E00B-4E9F-B83D-CBFB6E44C377Q37065594-DF5329EC-B010-4855-BE46-ACFFF48D34B9Q37598686-6239C638-4DD2-411D-B75E-857114A0B8C7Q38193337-411874C7-DEE1-4FA7-A0AC-9A33626228D2Q39496765-3CDE0B50-8604-45C8-956B-66310546A1C2Q40170003-D85EB576-681B-4CD6-BCF3-0A128FC0ED83Q41833155-695DE40C-22A5-4B93-A519-DCF2F8D13691Q42707641-2F9DA3B1-F2F9-4E6E-AD76-0929FF92C462Q46681089-C841C297-A4B9-4A5D-BF8E-B6EE07E7632CQ51177203-F124A3E0-1B81-4890-BC3F-A6437CB9AD11
P2860
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Antifungal resistance in non- albicans Candida species.
@en
type
label
Antifungal resistance in non- albicans Candida species.
@en
prefLabel
Antifungal resistance in non- albicans Candida species.
@en
P2093
P356
P1476
Antifungal resistance in non- albicans Candida species.
@en
P2093
Berjan Collin
Cornelius J. Clancy
M. Hong Nguyen
P356
10.1054/DRUP.1998.0059
P577
1999-02-01T00:00:00Z